The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for professional in gene and cell therapy. The ASGCT will be held in Los Angeles, USA from 16th May to 20th May 2023. It is the best place for people in the field to learn from the latest scientific research, stay up to date on new technologies in gene and cell therapy. In 2022, more than 7600 professional personnel around the world participate in ASGCT events (in-person and virtual attendance), including scientists, doctors, patients and advocators.
ARCE Therapeutics’ abstract “Development of a 3-Day DashCAR®-T Cell Therapy against C-Type Lectin-Like Molecule 1 (CLL-1) for Acute Myeloid Leukemia” had been accepted by ASGCT for the 2023 annual meeting. The study result will be presented by poster on 5/19/2023 12:00PM (PST Time).
Session Date/Time: 5/19/2023 12:00:00 PM
Session Title: Friday Poster Session
Your Presentation Time: 5/19/2023 12:00:00 PM
Final Abstract Number: 1298
Poster Board Number: 1298
第26屆美國基因與細胞治療學會(ASGCT)年會將於2023年5月16日至20日在美國洛杉磯舉行。ASGCT年會是全球基因與細胞治療領域最具規模的學術會議，也是提供最新基因與細胞治療發展並進行交流討論的國際平台。做為全球領先的基因與細胞治療學會會議，2022年的ASGCT年會吸引了近7600名來自世界各地的專業人士與會(包含線上會議)，其中包括科學家、醫生、患者、與擁護者。
承寶生技通過ASGCT大會審查，將於今年會議期間發表以DashCAR®技術所開發出針對治療急性骨髓白血病的CLL-1 CAR-T細胞治療研發成果。相關研究結果將於美西時間5/19 12:00PM以海報形式於ASGCT年會發表。